GSK-3039294

N/A

Report date: 2025/06/10 17:54:59

Base Information

Drug NameGSK-3039294
Drug Alias NameGSK-3039294GSK-294GSK-294A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerum amyloid P-component inhibitors
TargetsSerum amyloid P-component
Therapy Area/IndicationsAmyloidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsAmyloidosis

Other Information

ATC CodeN/A
Related LinksN/A